Clinical Trials Browser

ripretinib × 1 year × Clear all

NCT05957367 2026-03-06

A Study of Inlexisertib (DCC-3116) in Combination With Anticancer Therapies in Participants With Advanced Malignancies

Phase 1/2 Recruiting

GastrointestinalSarcoma

Gastrointestinal Stromal Tumors

NCT03673501 2026-02-05

INTRIGUE

Phase 3 Active not recruiting

453 enrolled 20 charts

GastrointestinalSarcoma

Gastrointestinal Stromal Tumors

NCT05734105 2025-12-17

INSIGHT

Phase 3 Active not recruiting

GastrointestinalSarcoma

Gastrointestinal Stromal Tumors

NCT06619275 2025-12-05

INTEREST

GastrointestinalSarcoma

Gastrointestinal Stromal Tumors